“…In this respect, two clinically evaluated dual COX/5-LOX inhibitors, licofelone and S-2474, also displayed cytokine-modulating properties on the production of TNF-a and/or interleukin-1b (IL-1b). 20,21 To our knowledge, few studies associated with this type of compounds have been reported, [22][23][24][25][26] and prior to this work the only report on the biological activity of such compounds, including compound 1, was described by Sang et al 26 This class of compounds was identified as tyrosine kinase inhibitors of the human epidermal growth factor receptor (HER) family (toward HER1, HER2, and HER4). In addition, it should be noted that compound 1 can also be named 1-(4-bromophenyl)-5-nitro-1k 4 -benzo[1,3,2]dithiazole 3,3-dioxide, according to the Lambda Convention.…”